Funding for this research was provided by:
Danmarks Grundforskningsfond (DNRF107)
Received: 22 October 2020
Accepted: 8 June 2021
First Online: 1 July 2021
: The University of Copenhagen has filed a patent application relating to X409 mucin-binding peptides (EPO application EP21177857.6, pending). R.N., C.B., Y.N., B.H., and H.C. are named inventors. GlycoDisplay Aps, Copenhagen, Denmark, has obtained a license to the patent application. Y.N. and H.C. are co-founders of GlycoDisplay Aps and hold ownerships and financial interest in the company. The remaining authors declare no competing interests.